HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

She identified 2 primary frontiers for clinical investigation: the eradication of persistent cancer cells and the management ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.

Docetaxel rechallenge significantly improved survival compared with cabazitaxel in certain men with metastatic ...

India has about 2.5 million people living with cancer and around 100 million people with rare diseases, many of whom require medicines that fall outside insurance coverage and price control ...

Chemotherapy causes harsh side effects because it targets fast-growing cancer cells along with healthy cells like hair follicles, gut lining, and bone marrow. This leads to fatigue, nausea, hair loss, ...

Exploring new methodologies in cancer treatment, industry experts emphasize the importance of region-specific strategies and innovations in India’s oncology sector amid rising challenges in care ...

Georgia lawmakers are considering a bill to make a controversial anti-parasitic drug available over the counter.

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...